The addition of lithium to carbamazepine. Antidepressant efficacy in treatment-resistant depression

Archives of General Psychiatry
K G Kramlinger, R M Post

Abstract

The addition of lithium carbonate to various antidepressant agents, including heterocyclics and monoamine oxidase inhibitors, has been reported to rapidly effect an antidepressant response in otherwise treatment-unresponsive depressed patients. Fifteen depressed patients diagnosed by DSM-III criteria who had not responded to double-blind treatment with carbamazepine were treated with the blind addition of lithium to carbamazepine. Eight patients (53%) responded with a moderate to marked improvement. The time to onset of substantial clinical improvement was rapid; ie, the mean (+/- SD) was 4.1 +/- 2.4 days for lithium potentiation compared with 9.7 +/- 4.1 days in a separate group of depressed patients responding to lithium alone. Side effects during carbamazepine-lithium combination therapy were minimal. The mechanisms by which lithium appears to rapidly potentiate the effects of carbamazepine in treatment-resistant depression are discussed.

Citations

Oct 1, 1992·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·V Sharma, E Persad
Sep 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·P J CowenD L Julier
Dec 24, 1998·Journal of Clinical Psychopharmacology·M A FryeT A Ketter
Jun 5, 2003·Bipolar Disorders·Charles L Bowden
Apr 28, 2005·Expert Review of Neurotherapeutics·Philip B Mitchell, Gin S Malhi
Jan 7, 2006·CNS Drugs·Daniel LinLakshmi N Yatham
Feb 25, 2009·Expert Opinion on Pharmacotherapy·Jean-Michel Azorin, Arthur Kaladjian
Mar 1, 1994·The Australian and New Zealand Journal of Psychiatry·M J Dyck
Dec 7, 2002·CNS Drugs·Gin S MalhiShahzad Salim
May 3, 2002·Molecular Psychiatry·P E KeckM Tohen
Jan 31, 2002·Annual Review of Medicine·Philip B Mitchell, Gin S Malhi
Nov 26, 2003·Bipolar Disorders·S Nassir GhaemiFrederick K Goodwin
May 18, 2004·The Australian and New Zealand Journal of Psychiatry·UNKNOWN Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Bipolar Disorder
Nov 1, 1995·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·M SrisurapanontA P Zis
Mar 18, 2003·Journal of Clinical Psychopharmacology·Carrie L Ernst, Joseph F Goldberg
Apr 27, 2004·International Clinical Psychopharmacology·Peter H Silverstone, Trevor Silverstone
Jan 1, 1992·Pharmacology & Toxicology·J Rybakowski
Jan 6, 2000·The Australian and New Zealand Journal of Psychiatry·H K ManjiR H Lenox
Oct 1, 1992·Journal of Child Neurology·W A Weinberg, R A Brumback
Apr 14, 2005·The Psychiatric Clinics of North America·Steven L Dubovsky

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.